Literature DB >> 11714060

The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA).

M Siemann1, M Koch-Dörfler.   

Abstract

The sensitivity of a sandwich enzyme-linked immunosorbent assay (ELISA) for detecting Aspergillus galactomannan was evaluated with 66 serum samples and 113 specimens of the respiratory tract obtained from 52 patients with pulmonary diseases. The patients were divided into five groups: proven invasive pulmonary aspergillosis (IPA) (five patients), probable IPA (seven patients), Aspergillus colonization (eight patients) or unlikely Aspergillus infection (27 patients). Another five patients with doubtful diagnostic test results are discussed in detail. The results of the Platelia Aspergillus ELISA (Sanofi Pasteur, Freiburg, Germany) in testing specimens of the respiratory tract were 90% sensitivity in proven (serum 38%), 60% in probable (serum 37%) and 71% in Aspergillus colonization (serum 0%). Furthermore, 85% of the Aspergillus spp. from positive cultures of specimens of the respiratory tract were also detected in the ELISA. A total of 57% of the culture negative specimens of patients with a least one positive culture or proven aspergillosis in a series of specimens were positive in the ELISA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714060

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Authors:  Claudine Pinel; Hélène Fricker-Hidalgo; Bernadette Lebeau; Frédéric Garban; Rébecca Hamidfar; Pierre Ambroise-Thomas; Renée Grillot
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-10-20       Impact factor: 2.490

3.  Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.

Authors:  M Hong Nguyen; Reia Jaber; Helen L Leather; John R Wingard; Benjamin Staley; L Joseph Wheat; Christina L Cline; Maher Baz; Kenneth H Rand; Cornelius J Clancy
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

4.  Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.

Authors:  Cornelius J Clancy; Reia A Jaber; Helen L Leather; John R Wingard; Benjamin Staley; L Joseph Wheat; Christina L Cline; Kenneth H Rand; Denise Schain; Maher Baz; M Hong Nguyen
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

5.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

Review 6.  Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

Authors:  P Lewis White; John R Wingard; Stéphane Bretagne; Jürgen Löffler; Thomas F Patterson; Monica A Slavin; Rosemary A Barnes; Peter G Pappas; J Peter Donnelly
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

Review 7.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.